Precigen Inc (PGEN)

Mar 27, 2025

Is Precigen (PGEN) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 27, 2025

Mar 23, 2025

Precigen, Inc. (NASDAQ:PGEN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 23, 2025

Mar 22, 2025

Cantor Fitzgerald raises Precigen stock target to $5 By Investing.com - Investing.com Australia

Mar 22, 2025

Mar 22, 2025

10 Hot Biotech Stocks Under $5 - Insider Monkey

Mar 22, 2025

Mar 21, 2025

Precigen’s Earnings Call: Positive Outlook Amid Challenges - TipRanks

Mar 21, 2025

Mar 21, 2025

Precigen Inc (PGEN) Q4 2024 Earnings Report Preview: What To Exp - GuruFocus.com

Mar 21, 2025

Mar 21, 2025

Precigen’s SWOT analysis: biotech firm’s stock poised for potential launch By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

Analysts Are Bullish on Precigen Stock (PGEN) Amid Positive Pipeline Developments - Markets Insider

Mar 21, 2025

Mar 21, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Deadline in Securities Class Action First Filed by the Firm – PGEN, XON - Business Wire

Mar 21, 2025

Mar 21, 2025

Stifel maintains Precigen stock Buy rating with $7 target By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 20, 2025

Precigen’s SWOT analysis: biotech firm’s stock poised for potential launch - Investing.com India

Mar 20, 2025

Mar 20, 2025

Expert Outlook: Precigen Through The Eyes Of 4 Analysts - Nasdaq

Mar 20, 2025

Mar 20, 2025

Cantor Fitzgerald raises Precigen stock target to $5 - Investing.com

Mar 20, 2025

Mar 20, 2025

Stifel maintains Precigen stock Buy rating with $7 target - Investing.com

Mar 20, 2025

Mar 20, 2025

H.C. Wainwright reiterates buy on Precigen stock, maintains $6 target By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

H.C. Wainwright reiterates buy on Precigen stock, maintains $6 target - Investing.com

Mar 20, 2025

Mar 20, 2025

Earnings call transcript: Precigen Q4 2024 sees net loss, stock rises By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance

Mar 20, 2025

Mar 20, 2025

Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - GuruFocus.com

Mar 20, 2025

Mar 20, 2025

Precigen earnings beat by $0.02, revenue fell short of estimates - Investing.com Canada

Mar 20, 2025

Mar 19, 2025

Precigen Reports Progress and Financial Results for 2024 - TipRanks

Mar 19, 2025

Mar 19, 2025

Precigen Reports Full Year 2024 Financial Results and Business Updates - The Malaysian Reserve

Mar 19, 2025

Mar 19, 2025

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 19, 2025

Mar 19, 2025

Earnings call transcript: Precigen Q4 2024 sees net loss, stock rises - Investing.com Canada

Mar 19, 2025

Mar 19, 2025

Precigen Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025

Mar 19, 2025

Precigen Inc Reports Q4 Net Loss of $(0.47) Per Share, Revenue o - GuruFocus.com

Mar 19, 2025

Mar 19, 2025

PRECIGEN, INC. SEC 10-K Report - TradingView

Mar 19, 2025

Mar 18, 2025

How Do Things Look For Precigen Inc (NASDAQ: PGEN) In The Short-Term? - Stocks Register

Mar 18, 2025

Mar 17, 2025

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Precigen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Business Wire

Mar 17, 2025

Mar 14, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World

Mar 14, 2025

Mar 14, 2025

Analysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $7.00 - MarketBeat

Mar 14, 2025

Mar 13, 2025

Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - Quantisnow

Mar 13, 2025

Mar 13, 2025

Precigen Gene Therapy Pioneer Reveals 2024 Performance: Key Financial Results Coming March 19 - StockTitan

Mar 13, 2025

Mar 11, 2025

Exploring High Growth Tech Stocks In The US Market - Simply Wall St

Mar 11, 2025

Mar 11, 2025

Precigen, Inc. (NASDAQ:PGEN) Stock Holdings Increased by Rhumbline Advisers - Defense World

Mar 11, 2025

Mar 11, 2025

Precigen (PGEN) Projected to Post Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 05, 2025

Is Precigen Inc’s (NASDAQ:PGEN) Stock On The Decline? - Stocks Register

Mar 05, 2025

Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025

Mar 01, 2025

Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 - Insider Monkey

Mar 01, 2025

Mar 01, 2025

Precigen (NASDAQ:PGEN) Shares Gap UpWhat's Next? - MarketBeat

Mar 01, 2025

Feb 28, 2025

Precigen (NASDAQ:PGEN) Shares Up 7.7%Time to Buy? - MarketBeat

Feb 28, 2025

Feb 28, 2025

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (NASDAQ:PGEN) - Seeking Alpha

Feb 28, 2025

Feb 28, 2025

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (PGEN) - Seeking Alpha

Feb 28, 2025

Feb 26, 2025

FDA advances Precigen’s gene therapy for respiratory disease By Investing.com - Investing.com Australia

Feb 26, 2025

Feb 26, 2025

FDA Accepts for Review Precigen RRP Gene Therapy Candidate - Genetic Engineering & Biotechnology News

Feb 26, 2025

Feb 25, 2025

Stifel maintains Precigen stock Buy rating, $7 target post-FDA update - Investing.com Australia

Feb 25, 2025

Feb 25, 2025

FDA Accepts BLA for Precigen’s Recurrent Respiratory Papillomatosis Gene Therapy PRGN-2012 With Priority Review - CGTLive™

Feb 25, 2025

Feb 25, 2025

Decades in, this Germantown biopharma is on the cusp of bringing its first product to market - The Business Journals

Feb 25, 2025